Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-10-27
1998-08-11
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 2613, A61K 3170
Patent
active
057927529
ABSTRACT:
Site 1- and site 2-selective derivatives of cAMP have been found to inhibit the growth of a variety of cancer and leukemic cells. The compounds have been found to have a synergistic effect in cancer and leukemic cell growth inhibition when a site 1-selective compound is used in combination with a site 2-selective compound.
REFERENCES:
patent: 3849397 (1974-11-01), Robins et al.
patent: 3849553 (1974-11-01), Dea et al.
patent: 3856776 (1974-12-01), Cehovic et al.
patent: 3948886 (1976-04-01), Shuman et al.
patent: 4058659 (1977-11-01), Robins et al.
patent: 4208406 (1980-06-01), Lapinet et al.
patent: 4369181 (1983-01-01), Miller et al.
patent: 4861873 (1989-08-01), Robins et al.
Tortora et al., "Phase I Clinical Study with 8-Chloro-cAMP and Evaluation of Immunological Effects in Cancer Patients," Clinical Cancer Research, 1, 377-384 (Apr. 1995).
Y. S. Cho-Chung(I), "Site Selective 8-Chloro-Cyclic Adenosine 3',5"-Monophosphate as a Biologic Modulator of Cancer: Restoration of Normal Control Mechanisms," J. Nat. Cancer Inst. USA, 81(13), 982-987 (1989).
Katsaros et al., "Site-Selective Cyclic AMP Analogs Provide a New Approach Control of Cancer Cell Growth," FEBS Letters, 223(1), 97-103 (1987).
Cho-Chung et al.(I), "Site Selective cAMP Analogs are Cytostatic and Differentiating Agents for a Spectrum of Human Cancer Cell Lines: Potential for Application to Chemotherapy," Proc. Am. Soc. Clin. Oncology, 6, Abstr. 62, p. 17, 1987.
Cho-Chung et al. (II), "In vivo Inhibition of Growth of Two Hormone-Dependent Mammary Tumors by Dibutyryl Cyclic AMP," Science, 183, 87-88 (1974).
Tagliaferri et al.(I), "Reverse Transformation of Harvey Murine Sarcoma Virus-transformed NIH/3T3 Cells by Site-Selective Cyclic AMP Analogs," J. Biol. Chem., 263(1), 409-416 (1988).
Tagliaferri et al.(II), "Synergistic Inhibition of Growth of Breast and Colon Human Cancer Cell Lines by Site-Selective Cyclic AMP Analogues," Cancer Res., 48, 1642-1650 (1988).
Tortora et al.(I), "Site-Selective cAMP Analogs at Micromolar Concentrations Induce Growth Arrest and Differentiation of Acute Promyelocytic, Chronic Myelocytic, and Acute Lymphocytic Human Leukemia Cell Lines," Blood, 71(1), 230-233 (1988).
Niles et al., "Regulation of Phosphatidylcholine Metabolism By Cyclic AMP in a Model Alveolar Type 2 Cell Line," J. Biol. Chem., 254(11), 4324-4326 (1979).
Miller et al., "Synthesis and Enzymatic and Inotropic Activity of Some New 8-Substituted and 6,8-Disubstituted Derivatives of Adenosine Cyclic 3',5"-Monophosphate," J. Med. Chem., 23, 242-251 (1980).
Mineyama et al., "Synthesis and Biological Activity of 8-Haloadenosine 3',5"-Cyclic Phosphates," J. Carbohydrates Nucleosides Nucleotides, 1(1), 55-60 (1974).
Tsuji et al., "Neuronal Differentiation of Oat Cell Carcinoma In Vitro by Dibutyryl Cyclic Adenosine 3',5"-Monophosphate," Cancer Letters, 1, 311-318 (1976).
Helson et al., "A Rationale for the Treatment of Metastatic Neuroblastoma," J. Nat. Cancer Inst. USA, 57(3), 727-729 (1976).
Holmgren et al., "In Vivo Modulation of Intracellular cAMP and Cell Growth of a Lymphatic Tumour in Mice by Cholera Toxin," Expmntl. Cell Res., 108, 31-39 (1977).
Prasad, "Differentiation of Neuroblastoma Cells in Culture," Bio. Rev., 50, 129-165 (1975).
Rannels et al., "Two Different Intrachain cAMP Binding Sites of cAMP-dependent Protein Kinases," J. Bio. Chem., 255(15), 7085-7088 (1980).
Ogreid et al., "Activation of Protein Kinase Isozymes by Cyclic Nucleoside Analogs Used Singly or in Combination," Eur. J. Biochem, 150, 219-227 (1985).
Robinson-Steiner et al., "Probable Involvement of Both Intrachain cAMP Binding Sites in Activation of Protein Kinase," J. Biol. Chem., 258, 1032-1040 (1983).
T. Beardsley, "Trends in Cancer Epidemiology--A War Not Won," Scientific American, 270(1), 130-138 (1994).
Y.S. Cho-Chung(II), "Role of Cyclic AMP Receptor Proteins in Growth, Differentiation, and Suppression of Malignancy: New Approaches to Therapy," Cancer Research, 50, 7093-7100 (1990).
Tortora et al. (II), "Differentiation of HL-60 Leukemia by Type I Regulatory Subunit Antisense Oligodeoxynucleotide of cAMP-Dependent Protein Kinase," Proc. Nat. Acad. Sci. USA, 88, 2011-2015 (1991).
Cho-Chung et al. (III), "Role of Site-Selective cAMP Analogs in the Control and Reversal of Malignancy," Pharmac. Ther., 50(1), 1-33 (1991).
Tortora et al. (III), "Phase I Clinical Study with 8-Chloro-cAMP and Evaluation of Immunological Effects in Cancer Patients," Clinical Cancer Research, 1(4), in press (1995).
Tortora et al. (IV), "Phase I Trail and Evaluation of Immunological Effects of 8-Cl-cAMP in Cancer Patients," Proc. Am. Assoc. Cancer Res., 35, Abstract No. 1455, p. 244, Mar. 1994; Presented at the 84th Mtg. of Am. Assoc. Cancer Res., Apr. 10-13, 1994, San Francisco, CA.
Harris et al.(I), "Phase I Study of 8-Chloro cAMP," Abstr. of Presentation made at Conf. on Cell Signalling and Cancer Treatment, sponsored by Am Assoc. Cancer Research and EORTC, Puerto Rico, Dec. 1993.
Harris et al.(II), "Clinical Development of Novel Anti-Cancer Drugs Bryostatin and 8 Chloro Cyclic AMP," Abstr. of Presentation made at Conf. on Cell Signalling and Cancer Treatment, sponsored by Am Assoc. Cancer Research and EORTC, Puerto Rico, Dec. 1993.
Leonard et al., "Study of Signal Transduction, 8 Chlorocylic AMP in Human Breast Cancer, Phase I and Pharmacological Study," Abstract of presentation at Lancet Conference 1994, United Kingdom.
Cho-Chung Yoon Sang
Robins, deceased Roland K.
Crane L. Eric
Kight John
The United States of America as represented by the Department of
LandOfFree
8-chloro camp and related camp compounds as antineoplastic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-chloro camp and related camp compounds as antineoplastic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-chloro camp and related camp compounds as antineoplastic agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-389065